These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36921670)

  • 21. The role of peptide-based therapeutics in oncotherapy.
    Timur SS; Gürsoy RN
    J Drug Target; 2021 Dec; 29(10):1048-1062. PubMed ID: 33775190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide.
    Suwatthanarak T; Tanaka M; Miyamoto Y; Miyado K; Okochi M
    Chem Commun (Camb); 2021 May; 57(40):4906-4909. PubMed ID: 33870995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration.
    Sakamoto K; Adachi Y; Komoike Y; Kamada Y; Koyama R; Fukuda Y; Kadotani A; Asami T; Sakamoto JI
    Biochem Biophys Res Commun; 2017 Jan; 483(1):183-190. PubMed ID: 28039053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors.
    Groner B; Weber A; Mack L
    Bioengineered; 2012; 3(6):320-5. PubMed ID: 22825353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic peptides: new arsenal against drug resistant pathogens.
    Mok WW; Li Y
    Curr Pharm Des; 2014; 20(5):771-92. PubMed ID: 23688084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mimetics of the peptide beta-strand.
    Glenn MP; Fairlie DP
    Mini Rev Med Chem; 2002 Oct; 2(5):433-45. PubMed ID: 12370045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases.
    Tasdemiroglu Y; Gourdie RG; He JQ
    Eur J Pharmacol; 2022 Oct; 932():175192. PubMed ID: 35981605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration.
    Getz JA; Cheneval O; Craik DJ; Daugherty PS
    ACS Chem Biol; 2013; 8(6):1147-54. PubMed ID: 23537207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide Agonists and Antagonists with Potential Application in Neurological Disorders.
    Russo A; La Manna S; Morelli G; Novellino E; Marasco D
    Recent Pat CNS Drug Discov; 2016; 10(2):76-89. PubMed ID: 27108811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venoms as a platform for human drugs: translating toxins into therapeutics.
    King GF
    Expert Opin Biol Ther; 2011 Nov; 11(11):1469-84. PubMed ID: 21939428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of Pigment Epithelium-derived Factor and Its Peptides on Proliferation,
Apoptosis and Migration of Non-small Cell Lung Cancer].
    Chao Z; Qin X; Jia C; Qin H; Zhang H
    Zhongguo Fei Ai Za Zhi; 2021 Dec; 24(12):829-837. PubMed ID: 34743495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing aromatic N-cadherin mimetic short-peptide-based bioactive scaffolds for controlling cellular behaviour.
    Kaur H; Roy S
    J Mater Chem B; 2021 Aug; 9(29):5898-5913. PubMed ID: 34263278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
    Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
    Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptides as therapeutics with enhanced bioactivity.
    Goodwin D; Simerska P; Toth I
    Curr Med Chem; 2012; 19(26):4451-61. PubMed ID: 22830348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing Schwann cell migration using concentration gradients of laminin-derived peptides.
    Motta CMM; Endres KJ; Wesdemiotis C; Willits RK; Becker ML
    Biomaterials; 2019 Oct; 218():119335. PubMed ID: 31302351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.
    Poller W; Rother M; Skurk C; Scheibenbogen C
    Br J Pharmacol; 2012 Apr; 165(7):2044-58. PubMed ID: 22035209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptides as Therapeutic Agents for Inflammatory-Related Diseases.
    La Manna S; Di Natale C; Florio D; Marasco D
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide therapeutics from venom: Current status and potential.
    Pennington MW; Czerwinski A; Norton RS
    Bioorg Med Chem; 2018 Jun; 26(10):2738-2758. PubMed ID: 28988749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo.
    Smallwood TB; Navarro S; Cristofori-Armstrong B; Watkins TS; Tungatt K; Ryan RYM; Haigh OL; Lutzky VP; Mulvenna JP; Rosengren KJ; Loukas A; Miles JJ; Clark RJ
    J Biol Chem; 2021 Jul; 297(1):100834. PubMed ID: 34051231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass Spectrometry Approaches Empowering Neuropeptide Discovery and Therapeutics.
    Anapindi KDB; Romanova EV; Checco JW; Sweedler JV
    Pharmacol Rev; 2022 Jul; 74(3):662-679. PubMed ID: 35710134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.